LENZ Therapeutics, Inc.
LENZ
$7.34
$0.050.69%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 258.39M | 292.35M | 202.17M | 209.52M | 193.98M |
| Total Receivables | 2.44M | 2.43M | 1.10M | 1.30M | -- |
| Inventory | 3.50M | 2.94M | 949.00K | -- | -- |
| Prepaid Expenses | 4.04M | 3.70M | 2.78M | 2.67M | 3.77M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 114.00K | 114.00K |
| Total Current Assets | 268.37M | 301.41M | 207.00M | 213.60M | 197.86M |
|
|
|||||
| Total Current Assets | 268.37M | 301.41M | 207.00M | 213.60M | 197.86M |
| Net Property, Plant & Equipment | 1.72M | 1.92M | 2.11M | 2.13M | 2.00M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.45M | 2.54M | 1.60M | 1.60M | 1.40M |
| Total Assets | 272.54M | 305.88M | 210.70M | 217.33M | 201.25M |
|
|
|||||
| Total Accounts Payable | 10.93M | 4.17M | 4.32M | 2.85M | 3.66M |
| Total Accrued Expenses | 14.44M | 16.56M | 11.50M | 7.06M | 4.40M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 436.00K | 465.00K | 493.00K | 482.00K | 509.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 25.81M | 21.19M | 16.32M | 10.40M | 8.57M |
|
|
|||||
| Total Current Liabilities | 25.81M | 21.19M | 16.32M | 10.40M | 8.57M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 237.00K | 350.00K | 461.00K | 569.00K | 673.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 26.04M | 21.54M | 16.78M | 10.97M | 9.24M |
|
|
|||||
| Common Stock & APIC | 515.57M | 511.24M | 384.95M | 380.87M | 351.52M |
| Retained Earnings | -268.63M | -227.14M | -191.25M | -174.55M | -159.63M |
| Treasury Stock & Other | -450.00K | 242.00K | 227.00K | 38.00K | 123.00K |
| Total Common Equity | 246.49M | 284.34M | 193.93M | 206.37M | 192.01M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 246.49M | 284.34M | 193.93M | 206.37M | 192.01M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 246.49M | 284.34M | 193.93M | 206.37M | 192.01M |
|
|
|||||